The Role of Negative Controls in Shotgun Metagenomic Sequencing: Ensuring Data Integrity

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-20

Key Takeaways

• Negative controls are indispensable for shotgun metagenomics, serving to document reagent and environmental DNA contamination that can skew results, particularly in low-biomass samples where contaminants can be misidentified as true biological signals.
• A comprehensive negative control strategy necessitates multiple control types, including extraction blanks (for reagent/kit contamination), library preparation negatives (for adapter ligation/amplification/indexing contamination), and no-template controls (for amplification reagent contamination), processed concurrently with biological samples.
• Contamination sources can be traced by strategically placing controls throughout the workflow, with extraction blanks capturing contamination from lysis buffers and kits, while library preparation negatives identify issues arising from polymerases, primers, and indexing reagents.
• Bioinformatics analysis of negative controls involves taxonomic profiling to identify contaminant taxa, followed by computational filtering and comparison to biological samples, often utilizing contaminant watchlists to remove spurious detections and ensure data integrity.
• Reporting negative control results alongside biological sample data, including the number of controls, detected taxa, and filtering methods, is crucial for transparency and allows downstream users to assess the reliability of findings, especially in clinical and veterinary diagnostic contexts where false positives can lead to inappropriate antimicrobial use.

Shotgun metagenomic sequencing reads all nucleic acids present in a sample without prior target amplification, which makes it a powerful tool for pathogen detection, microbiome characterization, and antimicrobial resistance surveillance. The same untargeted nature creates a distinct vulnerability: contaminating DNA from reagents, laboratory environments, and processing equipment is sequenced alongside true sample DNA, and in low-biomass samples this background signal can dominate the results. Negative controls are the primary experimental safeguard against this problem. A negative control is a sample that contains no biological input but undergoes the same DNA extraction, library preparation, and sequencing steps as real samples. When analyzed alongside biological samples, negative controls reveal what contaminants are present, where they enter the workflow, and how much of the final sequencing output is background instead of true biological signal. This article explains how to design, process, analyze, and interpret negative controls in shotgun metagenomic experiments, with practical recommendations for library preparation, sequencing runs, and bioinformatics filtering. The guidance is written for biology students, researchers, laboratory professionals, and life-science practitioners who need to produce defensible metagenomic data.

Why Negative Controls Matter in Shotgun Metagenomics

Shotgun metagenomic sequencing does not rely on conserved primer sequences to amplify a specific genomic region. Instead, it fragments all DNA in a sample, ligates adapters, and sequences the resulting library. This approach captures bacteria, viruses, fungi, parasites, and host DNA in a single run, which enables detection of unexpected organisms and characterization of functional gene content. The tradeoff is that every source of DNA in the laboratory becomes a potential contributor to the sequencing output. Reagent manufacturers do not guarantee nucleic-acid-free reagents, laboratory air contains microbial DNA, surfaces harbor environmental organisms, and extraction kits have been repeatedly shown to introduce contaminating sequences into metagenomic datasets.

The problem is most severe in low-biomass samples. A clinical swab, a biopsy, or a filtered environmental sample may contain only nanograms of microbial DNA. If a DNA extraction kit introduces even a small amount of contaminating DNA, that contaminant can represent a large fraction of the total sequencing library. In samples with high microbial biomass, such as feces or rumen contents, contaminating DNA is diluted by the sheer quantity of true sample DNA and has less impact on relative abundance estimates. In low-biomass samples, contaminants can be misidentified as true pathogens or as dominant community members.

Research on clinical metagenomics has demonstrated the practical consequences of ignoring contamination. A framework that integrated negative controls, laboratory-specific contaminant watchlists, and computational filtering substantially reduced false-positive signals and improved viral genome recovery in clinical samples [<a href="#ref-1">1</a>]. The same work showed that spurious detections are a substantial risk when contamination-aware workflows are not used, particularly for low-biomass samples [<a href="#ref-1">1</a>]. Strain-resolved analysis of large clinical metagenomics datasets has revealed well-to-well contamination during DNA extraction, where samples on the same or adjacent rows or columns of an extraction plate shared strains that were not present in samples farther away [<a href="#ref-2">2</a>]. This contamination affected both negative controls and biological samples, and its impact was greater in samples with lower biomass [<a href="#ref-2">2</a>]. These findings establish that contamination is not a theoretical concern but a measurable phenomenon that degrades data quality in real experiments.

Negative controls serve three distinct purposes in a shotgun metagenomic experiment. First, they document the baseline contamination present in reagents and the laboratory environment at the time of processing. Second, they allow researchers to identify contaminant taxa and remove them from biological sample data during bioinformatics analysis. Third, they provide a quality metric that can be reported alongside results, giving reviewers and downstream users confidence that detected organisms are genuinely present in samples instead of artifacts of the workflow.

Types of Negative Controls and What Each Detects

Different negative controls capture different sources of contamination. A well-designed experiment includes multiple control types positioned throughout the workflow so that contamination can be traced to its point of entry.

Extraction Blanks

An extraction blank, also called a kit blank or extraction negative control, is a tube that contains no biological sample but is carried through the entire DNA extraction process. The extraction kit reagents, the tubes, the pipette tips, and the laboratory surfaces all contact this control. Any DNA introduced by these sources appears in the extraction blank. This is the most important negative control for most metagenomic experiments because DNA extraction kits are a well-documented source of contamination. Extraction blanks should be processed in the same batch as biological samples, using the same reagents, the same equipment, and ideally by the same operator.

Library Preparation Negatives

A library preparation negative control is a tube that contains no DNA but is carried through adapter ligation, amplification, and indexing steps. This control captures contamination introduced during library construction, including contaminants in polymerase master mixes, indexing primers, and adapter solutions. In experiments where extraction blanks are clean but library preparation negatives show contamination, the problem is in the library preparation reagents or environment instead of the extraction step.

No-Template Controls

A no-template control (NTC) is a PCR or amplification control that contains water or buffer instead of DNA template. In shotgun metagenomic library preparation, the amplification step can introduce contaminants from the polymerase, the primers, or the water. No-template controls are standard practice in amplification-based workflows and should be included in every library preparation batch.

Environmental Controls

Environmental controls capture contamination from the sampling environment. These are collected by exposing sterile collection devices or swabs to the air, surfaces, or equipment at the sampling site. In a study of amniotic fluid microbiota, researchers included negative controls from the operating room environment, surgical instruments, and laboratory experimental processes to elucidate background contamination at each step [<a href="#ref-3">3</a>]. This approach allowed the research team to distinguish organisms genuinely present in amniotic fluid from organisms introduced during sample collection or processing. Environmental controls are particularly important for low-biomass sampling sites such as surgical suites, clean rooms, or field collection sites.

Reagent Controls

Reagent controls are negative controls that test specific reagents for contamination. A researcher might run a control that includes only the lysis buffer, only the binding buffer, or only the elution buffer to identify which reagent introduces contaminating DNA. This level of granularity is useful when extraction blanks show contamination and the source needs to be identified. Reagent controls are more labor-intensive than extraction blanks and are typically used during troubleshooting instead of in every experiment.

Designing a Negative Control Strategy

The number and type of negative controls should be proportional to the expected biomass of the samples and the consequences of false-positive results. A high-biomass fecal microbiome study with hundreds of samples requires fewer controls per sample than a clinical study of low-biomass biopsies where a false pathogen detection could change patient management.

Control Frequency

A reasonable starting point is one extraction blank per extraction batch, one library preparation negative per library preparation batch, and one no-template control per amplification plate. For low-biomass studies, more controls are warranted. Some clinical metagenomics protocols include negative controls at a ratio of one control for every five to ten samples, particularly when samples are expected to contain very little microbial DNA. The exact ratio should be determined by the study design, the sample type, and the tolerance for false positives.

Control Placement in the Workflow

Negative controls should be processed in the same batch as biological samples, not in a separate batch. If controls are processed separately, they do not capture the contamination conditions of the actual experiment. Controls should be interspersed with samples on extraction plates and positioned to detect well-to-well contamination. Strain-resolved analysis has shown that contamination is more likely to occur among samples on the same or adjacent rows or columns of an extraction plate than among samples far apart [<a href="#ref-2">2</a>]. Placing negative controls adjacent to high-biomass samples can help detect cross-contamination during extraction.

Replicates

Running negative controls in duplicate or triplicate provides more reliable baseline contamination data. A single negative control may miss contaminants that are present at low levels or that vary between wells. Replicate controls allow researchers to distinguish consistent reagent contaminants from sporadic environmental contaminants. For critical experiments, such as clinical validation studies or studies that will inform regulatory decisions, replicate controls are strongly recommended.

Carrier RNA Considerations

Some low-biomass extraction protocols add carrier RNA to improve DNA recovery. Carrier RNA is itself a source of nucleic acid and can appear in sequencing data. If carrier RNA is used, a negative control that includes carrier RNA but no biological sample should be included to document the carrier RNA contribution. This control is distinct from a standard extraction blank because it contains the carrier RNA reagent.

Library Preparation and Sequencing Considerations

The library preparation step converts extracted DNA into a sequencing-ready library. This step introduces multiple opportunities for contamination, and negative controls must be carried through the same procedures as biological samples.

Indexing and Multiplexing

Shotgun metagenomic libraries are typically indexed with unique barcode sequences so that multiple samples can be sequenced in a single run. Indexing introduces two contamination risks. First, index primers can be contaminated with DNA from previous reactions. Second, index hopping or index switching can cause reads from one sample to appear in another sample's data. Negative controls should be indexed with unique barcodes and included in the multiplexed pool. This allows researchers to assess whether index contamination is present and to quantify its extent.

Amplification Cycles

Library amplification increases the amount of DNA available for sequencing but also amplifies any contaminating DNA present in the reaction. Contaminants that are present at very low levels in unamplified libraries can become abundant after amplification. Negative controls that undergo the same amplification cycles as biological samples will reveal the extent of this amplification. If negative controls show high read counts after amplification, the contamination level is too high for reliable low-biomass analysis.

Sequencing Run Placement

Negative control libraries should be distributed across the sequencing run instead of clustered in one lane or flow cell position. This distribution helps detect run-specific contamination and allows researchers to assess whether contamination varies by sequencing position. Some sequencing platforms have known positional effects, and distributing controls helps account for these effects.

Sequencing Depth for Controls

Negative controls should be sequenced at sufficient depth to detect low-abundance contaminants. A negative control that is sequenced to very low depth may miss contaminants that are present in the biological samples. The appropriate depth depends on the expected contaminant load and the sensitivity required for the study. For low-biomass studies, negative controls should be sequenced to a depth comparable to that of biological samples. For high-biomass studies, lower depth may be acceptable because contaminants represent a smaller fraction of the total signal.

Bioinformatics Analysis of Negative Controls

Negative controls are beyond a laboratory quality check. They are data that must be analyzed alongside biological samples to produce reliable results. The bioinformatics workflow for negative controls involves several steps.

Taxonomic Profiling of Controls

The first step is to taxonomically profile the negative controls using the same pipeline applied to biological samples. This produces a list of taxa detected in the controls, along with their relative abundances or read counts. The taxonomic profile of negative controls reveals the contaminant community present in the reagents and environment. Common reagent contaminants include genera such as Pseudomonas, Ralstonia, Burkholderia, Acinetobacter, and Bradyrhizobium, though the specific contaminants vary by laboratory and reagent lot.

Comparing Controls to Biological Samples

The contaminant taxa identified in negative controls should be compared to the taxa detected in biological samples. Any taxon present in both controls and samples is suspect, particularly if it is present at similar relative abundance in both. The comparison should be done at the species or strain level when possible, because genus-level comparisons can mask important differences. A species present in both controls and samples may be a true sample organism that also happens to be a reagent contaminant, or it may be entirely derived from contamination.

Computational Filtering Approaches

Several computational approaches can be used to remove contaminant signals from biological sample data. One common approach is to subtract taxa that appear in negative controls above a certain threshold. Another approach is to use the ratio of abundance in controls to abundance in samples to identify taxa that are likely contaminants. A more sophisticated approach uses strain-resolved analysis to track specific strains across samples and controls, which can reveal contamination that is not apparent from taxonomic profiling alone [<a href="#ref-2">2</a>].

The choice of filtering approach depends on the study design and the tolerance for false positives and false negatives. Aggressive filtering removes more potential contaminants but may also remove true signals, particularly for organisms that are genuinely present in both samples and the environment. Conservative filtering preserves more data but risks retaining contaminants that could be misinterpreted as true findings.

Contaminant Watchlists

A contaminant watchlist is a curated list of taxa known to contaminate metagenomic experiments in a particular laboratory or across the field. The clinical metagenomics framework that improved contamination management included laboratory-specific contaminant watchlists as a core component [<a href="#ref-1">1</a>]. Watchlists can be built from accumulated negative control data, published lists of common reagent contaminants, and knowledge of the local laboratory environment. When a taxon on the watchlist is detected in a biological sample, it triggers additional scrutiny before being reported as a true finding.

Reporting Negative Control Results

Negative control results should be reported alongside biological sample results in publications and clinical reports. The UK NHS Respiratory Metagenomics Network consensus statement identified the use of negative controls as a principle for setting detection thresholds and reporting detections [<a href="#ref-4">4</a>]. Reporting should include the number of controls used, the taxa detected in controls, the read counts or relative abundances in controls, and the filtering approach applied to biological sample data. This transparency allows readers to assess the reliability of the reported findings.

At a Glance: Negative Control Decision Table

Practical Implementation Steps

Implementing a negative control strategy requires planning before sample collection begins. The following steps outline a practical approach.

Step 1: Assess Sample Biomass

Estimate the expected microbial biomass of the samples before designing the control strategy. High-biomass samples such as feces, rumen contents, or soil require fewer controls per sample. Low-biomass samples such as swabs, biopsies, blood, or cerebrospinal fluid require more controls and more careful interpretation. If biomass is unknown, assume low biomass and design controls accordingly.

Step 2: Select Control Types

Choose the control types that match the workflow. Every experiment should include extraction blanks and library preparation negatives. Experiments with amplification steps should include no-template controls. Low-biomass clinical or environmental sampling should include environmental controls. Document the rationale for control selection in the study protocol.

Step 3: Determine Control Frequency

Set the number of controls based on batch size, sample biomass, and the consequences of false positives. A minimum of one extraction blank per batch and one library preparation negative per batch is standard. Increase control frequency for low-biomass studies, clinical samples, or studies where false positives would have serious consequences.

Step 4: Process Controls with Samples

Process negative controls in the same batches as biological samples, using the same reagents, equipment, and operators. Intersperse controls with samples on extraction plates. Use unique indexes for each control so that control data can be tracked independently.

Step 5: Sequence Controls at Adequate Depth

Include negative control libraries in the sequencing run at sufficient depth to detect low-abundance contaminants. For low-biomass studies, sequence controls to a depth comparable to biological samples. Distribute control libraries across the sequencing run.

Step 6: Analyze Controls with the Same Pipeline

Run negative controls through the same bioinformatics pipeline as biological samples. Generate taxonomic profiles for all controls. Compare control profiles to sample profiles at the species or strain level.

Step 7: Apply Filtering and Document Decisions

Apply computational filtering to remove contaminant signals from biological sample data. Document the filtering approach, the thresholds used, and the taxa removed. This documentation is essential for reproducibility and for reviewers who need to assess data quality.

Step 8: Report Control Results

Include negative control results in publications, reports, and data repositories. Report the number of controls, the taxa detected, the read counts, and the filtering approach. This transparency is a core principle of reliable metagenomic reporting [<a href="#ref-4">4</a>].

Records and Measurements for Negative Control Monitoring

Maintaining detailed records of negative control results allows laboratories to track contamination over time and identify changes in reagent lots, equipment, or laboratory conditions.

Contamination Log

Maintain a log of all negative control results, including the date, the operator, the reagent lot numbers, the extraction kit lot, the library preparation kit lot, and the sequencing run identifier. This log allows retrospective analysis when contamination problems emerge.

Baseline Contamination Profile

Build a baseline contamination profile for the laboratory by accumulating negative control data over multiple experiments. This profile documents the typical contaminant community and its abundance range. New experiments can be compared to the baseline to determine whether contamination levels are normal or elevated.

Reagent Lot Tracking

Track reagent lot numbers for all kits and reagents used in extraction and library preparation. Reagent contamination can vary between lots, and a new lot may introduce novel contaminants. If a new contaminant appears in negative controls, the reagent lot change is a likely cause.

Threshold Documentation

Document the thresholds used for contaminant filtering, including the read count or relative abundance thresholds for removing taxa detected in negative controls. Thresholds should be set based on the observed control data and the study requirements, and they should be reviewed periodically as more control data accumulates.

Escalation Criteria

Define criteria for escalating contamination problems. If negative controls show a sudden increase in read counts, if new contaminant taxa appear, or if contaminant taxa appear in biological samples at levels that cannot be confidently filtered, the experiment should be paused and the source of contamination identified before proceeding. Professional escalation may involve consulting with the laboratory director, the sequencing facility, or a bioinformatics specialist.

Common Failure Patterns in Negative Control Implementation

Several recurring problems undermine the effectiveness of negative controls in metagenomic experiments.

Controls Processed Separately from Samples

Negative controls that are processed in a separate batch from biological samples do not capture the contamination conditions of the actual experiment. This is one of the most common and most damaging errors. Controls must be processed in the same batch, with the same reagents, and by the same operator.

Insufficient Number of Controls

A single negative control for an entire study provides very limited information. Contamination varies between wells, between batches, and over time. Multiple controls distributed throughout the workflow provide a more reliable baseline. Studies with too few controls cannot adequately distinguish true signals from contamination.

Controls Sequenced at Inadequate Depth

Negative controls that are sequenced to very low depth may miss contaminants that are present in biological samples. If a contaminant is present at low abundance in the control but at higher abundance in samples due to amplification or sequencing variation, a shallowly sequenced control will not reveal it.

Ignoring Control Results

Some researchers collect negative control data but do not analyze it or report it. This defeats the purpose of including controls. Negative control data must be analyzed with the same rigor as biological sample data and must inform the interpretation of results.

Overly Aggressive Filtering

Filtering out all taxa detected in negative controls can remove true biological signals, particularly for organisms that are genuinely present in both samples and the environment. The goal of filtering is to remove contaminant signal while preserving true signal, which requires careful threshold selection and interpretation.

Failure to Detect Well-to-Well Contamination

Well-to-well contamination during DNA extraction is not always apparent from taxonomic profiling alone. Strain-resolved analysis can reveal contamination that occurs between samples on the same extraction plate [<a href="#ref-2">2</a>]. Laboratories that do not use strain-resolved methods may miss this type of contamination.

Limitations of Negative Controls

Negative controls are essential but not sufficient for ensuring data integrity in shotgun metagenomic sequencing. Several limitations must be understood.

Controls Do Not Capture All Contamination Sources

Negative controls capture contamination from reagents, laboratory surfaces, and processing steps, but they cannot capture every possible source. Contamination can occur during sample collection at the sampling site, during transport, or during storage before the sample reaches the laboratory. Environmental controls can help with collection-site contamination, but they cannot fully replicate the conditions of every sample.

Controls Cannot Fully Quantify Contamination

A negative control shows what contaminants are present and their relative abundance, but it does not precisely quantify how much contaminant DNA entered each biological sample. The amount of contamination varies between wells, between samples, and between processing steps. Negative controls provide an estimate of the baseline, not an exact measurement for each sample.

Low-Abundance Contaminants May Be Missed

Contaminants present at very low levels may not be detected in negative controls, particularly if the controls are sequenced at lower depth than biological samples. These low-abundance contaminants can still appear in biological samples, especially if they are preferentially amplified during library preparation.

Filtering Cannot Distinguish All True Signals from Contaminants

When a taxon is present in both negative controls and biological samples, computational filtering cannot always determine whether the biological sample signal is true, contaminant, or a mixture of both. This ambiguity is inherent to metagenomic analysis and must be acknowledged in interpretation.

Strain-Resolved Analysis Is Not Always Available

Strain-resolved analysis can detect contamination that is invisible to taxonomic profiling, but it requires higher sequencing depth and more sophisticated bioinformatics [<a href="#ref-2">2</a>]. Not all laboratories have the computational resources or expertise to perform strain-resolved analysis.

Diagnostic Performance Context

Understanding the diagnostic performance of metagenomic sequencing relative to other methods provides context for interpreting negative control results and setting expectations for detection sensitivity.

Sensitivity Compared to qPCR

Metagenomic sequencing does not always match the sensitivity of targeted molecular methods. In a study of bovine respiratory disease viruses, qPCR had higher diagnostic sensitivity than metagenomic sequencing for detecting bovine coronavirus and bovine herpesvirus type 1, while metagenomic sequencing had higher sensitivity for detecting bovine respiratory syncytial virus [<a href="#ref-5">5</a>]. These differences reflect the untargeted nature of metagenomics, which divides sequencing capacity across all organisms present instead of focusing on a single target.

Sensitivity for Bacterial Pathogens

Metagenomic sequencing also shows variable sensitivity for bacterial pathogen detection. A field evaluation of long-read metagenomic sequencing for bovine respiratory disease bacteria found that detection of key pathogens had low sensitivity, below 65 percent for most organisms and tests [<a href="#ref-6">6</a>]. This context is important because it means that a negative metagenomic result does not rule out the presence of a pathogen, and a positive result must be interpreted in light of the contamination risk documented by negative controls.

The Role of Viral Load

Viral load is a primary determinant of detection sensitivity in metagenomic sequencing, with reliable recovery achieved only at higher titers [<a href="#ref-1">1</a>]. Low viral loads may be missed entirely, or they may be indistinguishable from background contamination. Negative controls help establish the background level against which low-abundance detections must be evaluated.

Implications for Interpretation

These performance characteristics mean that negative controls are beyond a quality check but a central component of result interpretation. A detection that exceeds the negative control background by a small margin is less reliable than a detection that is far above background. Detection thresholds should be set with reference to negative control data, as recommended by the UK NHS Respiratory Metagenomics Network consensus statement [<a href="#ref-4">4</a>].

Welfare and Safety Context

The welfare and safety implications of metagenomic contamination extend beyond data quality. In clinical and veterinary settings, false-positive results can lead to unnecessary treatment, delayed diagnosis of the true condition, or inappropriate antimicrobial use. False-negative results can lead to missed diagnoses and delayed treatment.

Clinical Diagnostic Context

In clinical metagenomics, the consequences of contamination are direct and serious. A contaminant misidentified as a pathogen could lead to unnecessary antimicrobial therapy, which carries risks of adverse drug reactions and contributes to antimicrobial resistance. The UK NHS Respiratory Metagenomics Network consensus statement was developed specifically because reporting and interpretation of metagenomic results were heterogeneous and often at risk of bias or subjective interpretation [<a href="#ref-4">4</a>]. Negative controls are a core component of standardizing this process.

Veterinary Diagnostic Context

In veterinary medicine, metagenomic sequencing is being applied to respiratory disease diagnosis in cattle and other livestock [<a href="#ref-5">5</a>][<a href="#ref-6">6</a>]. False-positive detections could lead to unnecessary treatment of animals, increased antimicrobial use, and economic losses for producers. False-negative results could delay treatment of genuinely infected animals. The same contamination-aware principles that apply to human clinical metagenomics apply to veterinary applications.

Antimicrobial Resistance Surveillance

Metagenomic sequencing is increasingly used to detect antimicrobial resistance genes in livestock and environmental samples [<a href="#ref-6">6</a>]. Contamination can lead to false detection of resistance genes, which could misinform antimicrobial stewardship decisions. Negative controls are essential for ensuring that resistance gene detections reflect the sample instead of the laboratory environment.

Laboratory Safety

Working with metagenomic samples involves handling potentially infectious material. Standard laboratory safety practices, including biosafety cabinet use, personal protective equipment, and proper waste disposal, apply to all metagenomic workflows. Negative controls do not replace these safety measures but complement them by documenting the laboratory environment.

Professional Escalation Criteria

Researchers and laboratory professionals should know when to escalate contamination problems beyond their immediate control.

Escalate When Contamination Levels Are Unacceptable

If negative controls consistently show high read counts or if contaminant taxa dominate the control profiles, the experiment should be paused. The source of contamination should be identified and addressed before proceeding. This may involve changing reagent lots, cleaning laboratory surfaces, or revising protocols.

Escalate When Contamination Affects Biological Sample Interpretation

If contaminant taxa appear in biological samples at levels that cannot be confidently distinguished from true signals, escalate to a bioinformatics specialist or laboratory director. The decision to report or withhold a detection should be made with input from someone with experience in metagenomic data interpretation.

Escalate When Well-to-Well Contamination Is Suspected

If strain-resolved analysis reveals well-to-well contamination, escalate to the laboratory director and the sequencing facility. Well-to-well contamination indicates a problem with extraction or liquid handling procedures that requires protocol revision [<a href="#ref-2">2</a>].

Escalate When Reporting to Clinical or Regulatory Audiences

When metagenomic results will be used for clinical decisions, regulatory submissions, or other high-stakes purposes, involve appropriate expertise in the interpretation and reporting process. The consensus statement from the UK NHS Respiratory Metagenomics Network provides principles for this process [<a href="#ref-4">4</a>].

Escalate When Contamination Patterns Change Suddenly

If negative control profiles change dramatically without an obvious cause, escalate to investigate potential reagent lot changes, equipment malfunctions, or laboratory environment changes. A sudden change in contamination patterns may indicate a new contamination source that requires investigation.

Frequently Asked Questions

What is the difference between an extraction blank and a no-template control?

An extraction blank is a tube with no biological sample that is carried through the entire DNA extraction process, including lysis, binding, washing, and elution. It captures contamination from extraction reagents, tubes, pipette tips, and laboratory surfaces. A no-template control is a reaction that contains water or buffer instead of DNA template and is used in amplification steps. It captures contamination from polymerase, primers, water, and the amplification environment. Both are needed because they detect contamination at different points in the workflow.

How many negative controls should I include in my metagenomic experiment?

The number depends on sample biomass, batch size, and the consequences of false positives. A minimum of one extraction blank per extraction batch and one library preparation negative per library preparation batch is standard. Low-biomass studies, clinical samples, and studies where false positives have serious consequences warrant more controls, potentially one control for every five to ten samples. Replicate controls provide more reliable baseline data than single controls.

Can I subtract negative control data from biological sample data?

Subtraction is one approach, but it must be done carefully. Simply subtracting read counts from biological samples based on negative control data can remove true signals, particularly for organisms that are genuinely present in both samples and the environment. A more reliable approach is to use negative control data to identify contaminant taxa and then apply filtering thresholds based on the abundance of those taxa in controls relative to samples. The specific approach should be documented and justified in the analysis plan.

Why do my negative controls show different organisms than my biological samples?

Negative controls typically show a different community than biological samples because they contain only contaminants, not true sample organisms. Common reagent contaminants include environmental bacteria that thrive in laboratory conditions. The specific contaminants depend on the reagent lots, the laboratory environment, and the processing steps. If negative controls show the same dominant organisms as biological samples, this may indicate that the biological samples are heavily contaminated or that the controls were contaminated with sample DNA.

What should I do if my negative controls show high levels of contamination?

Pause the experiment and investigate the source of contamination. Check reagent lot numbers for recent changes, review laboratory cleaning procedures, and assess whether equipment such as pipettes or centrifuges may be contaminated. Process additional controls to confirm the contamination pattern. If the contamination cannot be resolved, consider changing reagent suppliers or consulting with the laboratory director. Do not proceed with biological sample interpretation until the contamination source is identified and addressed.

How do I know if a taxon detected in my biological samples is a contaminant?

Compare the taxon to the negative control profiles. If the taxon is present in negative controls at similar or higher relative abundance than in biological samples, it is likely a contaminant. If the taxon is present in controls at much lower abundance than in samples, it may be a true signal, but this should be interpreted cautiously. Strain-resolved analysis can provide additional confidence by determining whether the strain in the biological sample matches the strain in the controls [<a href="#ref-2">2</a>]. Detection thresholds should be set with reference to negative control data [<a href="#ref-4">4</a>].

Should negative controls be sequenced at the same depth as biological samples?

For low-biomass studies, negative controls should be sequenced at a depth comparable to biological samples so that low-abundance contaminants can be detected. For high-biomass studies, lower depth may be acceptable because contaminants represent a smaller fraction of the total signal. If negative controls are sequenced at very low depth, they may miss contaminants that are present in biological samples, which undermines their utility.

What should I report about negative controls in my publication?

Report the number and types of negative controls used, the taxa detected in controls, the read counts or relative abundances in controls, and the filtering approach applied to biological sample data. This transparency allows readers to assess the reliability of the reported findings. The UK NHS Respiratory Metagenomics Network consensus statement identifies the use of negative controls as a principle for setting detection thresholds and reporting detections [<a href="#ref-4">4</a>].

Related Bioinformatics Guides

• Metagenomic Contamination Control: Best Practices for Clean Data
• TMT Proteomics: Experimental Design, Labeling, and Data Analysis
• Metagenomics Data Analysis: From Raw Reads to Biological Insights
• Single-Cell RNA Sequencing Depth: A Cost-Benefit Analysis for Experimental Design
• Metagenomics Sequencing: Technologies and Considerations

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices

References and Further Reading

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.